•Clinical Trial: Predicting Response to Iron Therapy in Patients With Active Inflammatory Bowel Disease Using Hepcidin and Functional Iron Indices: A Multicentre Randomised Trial
•GPR15-guided CD8+ T regulatory cells control intestinal inflammation
•Smartly engineered biomaterials drive immune remodeling: A new paradigm for precise treatment of inflammatory bowel disease
•Digitally supported, patient-initiated care: Maintaining control of inflammatory bowel diseases while achieving high patient satisfaction
•Histological activity predicts relapse in pediatric ulcerative colitis despite mucosal healing: a multicenter study from the pediatric IBD Porto group of ESPGHAN
